Navigation Links
RetCam II Wide-Field Digital Pediatric Retinal Imaging System

ProductsRetCam II Wide-Field Digital Pediatric Retinal Imaging System
Company Clarity Medical Systems, Inc.
Item RetCam II Wide-Field Digital Pediatric Retinal Imaging System
Features 
  • 3 CCD Chip Video Camera: lightweight, easy to position, long cable for easy patient access
  • 5 changeable lenses; 130, 120, 80, 30, and Portrait
  • Large LCD Displays: Real-Time Video
  • Lighted Control Panel
  • Image Unit Holder allows simple one hand lens change
  • Camera Light Box with SVHS video output jack
  • FA Light Box (option) for Fluorescein Angiography
  • Storage Drawer for store tools, lenses, supplies
  • Dual DVD-RAM for easy backup
  • Inkjet Color Printer: real-time patient data report
  • Powerful RC II OS Software
  • Instant digital video clip capture (up to 20 seconds of real-time video)
  • Instant digital image capture
  • Multiimage data recall and display
  • Side-by-side image comparison
  • High resolution 24 bit color image
Description The RetCam II is a mobile, self-contained system that can be easily moved around the hospital or office. It provides state-of-the-art Wide-Field Pediatric Retinal Imaging. In just a few minutes you can do an entire exam and document almost the entire retina with as few as 5 photos. The heart of the RetCam II is our 3 CCD medical grade digital camera. Combined with our family of lenses, you can see a 130 degree field-of-view, real-time image of the pediatric retina. Seeing such a wide area makes diagnostics easier; there is less to "scan than when examining a small area of view (as with the indirect ophthalmoscope). In addition, the image and patient record is saved instantly as a digital file onto 9.4GB DVD-RAM media.

Our family of lenses contain the ROP 130 degree unit, Standard Childrens 120 degree unit, High magnification 30 degree unit, High contrast /adult 80 degree unit, and the flat field portrait lens used for external photographs. An optional Dye-sublimation Color Printer is used for physical photographic output of the images for inclusion to the patients report. Photo documentation of the frozen digital image eliminates interobserver variability.

A key feature of the RetCam II is the flat LCD color display that is easy to view during the exam, and ideal as a teaching tool for other physicians and hospital staff. The real-time image allows you to view the retina and anterior segment with ease. Also there is a 20 second video capture feature. A comprehensive database keeps track of each imaging session for the patient, allowing for later side-by-side or review of the case images. Also available is the Fluorescein Angiography option.

The RetCam II is the pediatric imaging tool of choice in the OR, NICU and PICU for documenting and managing Retinoblastoma, Retinopathy of Prematurity, Shaken Baby Syndrome and other pediatric eye diseases.

Info Clarity Medical Systems, Inc.
Customer Service: (800) 215-6005
Web site: http://www.claritymsi.com/

Related medicine products :

1. KOWA nonmyd 7 / VK-2 Digital Imaging System
2. Projection Digital Lensmeter LM-770
3. KOWA nonmyd a-D / VK-2 Digital Imaging System
4. Coolscope Digital Microscope
5. MIC-D Digital Microscope
6. Airfuge Ultracentrifuge - For 60 Hz, 120V; with Digital Tachometer
7. Quebec Darkfield Digital Colony Counter, 110V with USA Cord
8. Quebec Darkfield Digital Colony Counter, 220V with EU Cord
9. DS-5M-L1 Digital Sight Camera System
10. Magnafire SP Digital Camera
11. ODEI75D Digital / Video Camera
... The Portex® Thermovent® T helps provide p...y patient. It is small and extremely lightweight m...s adults. With a high rate of heat and moisture re...retion retention., ,All HMEs and filters have ISO...
... The Portex® Thermovent® T helps provide p...y patient. It is small and extremely lightweight m...s adults. With a high rate of heat and moisture re...retion retention., ,All HMEs and filters have ISO...
... The Portex® Thermovent® T helps provide p...y patient. It is small and extremely lightweight m...s adults. With a high rate of heat and moisture re...retion retention., ,All HMEs and filters have ISO...
Clear-Therm™ with Flextube
Medicine Products:
(Date:11/21/2009)...ewswire-USNewswire/ -- Tonight, in a partisan vote...,s version of the government takeover of health ca... in this bill; like the public option, employer an...or elective abortion, which is the most onerous an...vides subsidies for private plans that cover elect...
(Date:11/21/2009)...ey Provisions of Legislation, Continues Push for P...Ill., Nov. 21 With th...rk Affordable Health Care for America Act (H.R. 39...lation forward, Congress has taken decisive steps ...day, AARP hosted an educational forum to discuss t...
(Date:11/21/2009)...ll, president and chief executive officer of the A...following statement regarding the inclusion of cog...ual wellness for Medicare beneficiaries in "T...; that was introduced last night: , ...-- Eric J. Hall, president and chief executive off...
(Date:11/20/2009)...Newswire-USNewswire/ -- The American Academy of A...re reform legislation released this week to contai...ndividual coverage mandate. The actuaries said tha...ze adverse selection stemming from more restrictiv..., "The individual mandate language should be st...
(Date:11/20/2009)...ire-USNewswire/ -- The American Dental Association...ration (FDA) to establish appropriate classificati...oncern about the safety of whitening products that...fessional consultation or examination by a dentist...mically based tooth whitening or bleaching agents ...
Breaking Medicine News(10 mins):Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2
...SOFT (OCuSOFT,Inc.), a company specializing in oph...lmologists and optometrists, is pleased to announc...., to its Optometric Scientific,Advisory Board. *...d to playing a key role in the center,s developmen...
...ograms and support services in Los ...Lupus Foundation of,America (LFA) and Maybelline(R...ly Foundation hosted the First Annual "Butterflies...than 300,celebrities and guests who helped raise f...
...Dental,Association (ADA) House of Delegates called...nderstand the materials used to create dental fill... ease of placement, durability,and relative costs ...her outlets, the,association wants to ensure its a...
...high Circumference, LAS VEGAS, Oct. 2 Ariana Cos... America to offer Syneron,s VelaShape, the only,FD...inimize cellulite.,VelaShape uses elos technology ...e by almost an inch. Dr. Michael Belfiore of Aria...
...rns based on prostate cancer biopsy were found to ...this measurement could help predict the risk of pr... research published in the October 3 issue of JAMA...umors) of the prostate based on the patterns of pr...
...rch announced the,findings of the latest wave of i...urvey was completed in late June and found that ju...erage are definitely or very likely,to switch to M... switch, general satisfaction with their current,c...
Other Medicine News:Health News:Stars Shine on 'Butterflies Over Hollywood' for Lupus Foundation of America 2Health News:ADA Calls for Scientifically Accurate Patient Brochure Explaining Filling Choices 2Health News:Ariana First to Offer VelaShape in North America 2Health News:Using additional biopsy-scoring data may help determine prostate cancer prognosis 2
(Date:11/20/2009)...0 Smith & Nephew ( S...nnounce the signing of a technology development co...e that may lead to the creation of a fracture fixa...t of the limbs of soldiers who sustain battlefield...esearch Projects Agency (DARPA), the central resea...
(Date:11/19/2009).... 19 BioCryst Pharmaceut...ricing of a public offering of 5,000,000 shares of... gross proceeds of $48.75 million. All of the sha...ffective shelf registration statement previously f... BioCryst has also granted the underwriters a 30-d...
(Date:11/19/2009)...ov. 19 /PRNewswire-Asia/ -- ScinoPharm, a leading ...ts (APIs), announced that its,Tainan facility has ...from,SafeBridge(R) Consultants, Inc. The Certifica...ncy in the safe handling of potent active,pharmace... laboratories and,production areas used for the ma...
Breaking Medicine Technology:Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Norman Brinker Honored With 2009 Methodist Health System Folsom Leadership Award 48569 1Norman Brinker Honored With 2009 Methodist Health System Folsom Leadership Award 48569 2Norman Brinker Honored With 2009 Methodist Health System Folsom Leadership Award 48569 3Norman Brinker Honored With 2009 Methodist Health System Folsom Leadership Award 48569 4Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 1Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 2Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 3Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 4New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 1New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 2New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 3New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 4New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 5New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 6